Thomas has spent two years working in the auto journalism industry, contributing to a UK-based newspaper and writing for Euronewsweek. A full-time writer and lifelong engineering enthusiast, he now ...

Nissan GT-R50 takes the familiar R35 GT-R platform and turns it into an ultra-rare handbuilt anniversary supercar with dramatic styling, carbon fiber details and a much more exclusive presence. This ...

The Nissan N7 sedan and NX8 SUV built by the Dongfeng Nissan joint venture look like interesting candidates. Nissan plans to export lower-cost, China-made EVs to Canada. Tesla is already advertising ...

Nissan 72012.55%increase; up pointing triangle Motor said it expects a narrower annual net loss, even as its global sales continued to slide, citing one-off gains on revised U.S. emissions rules and ...

Nissan North America has agreed to a $1.5 million settlement to resolve a class action lawsuit stemming from a data breach that began around November 7, 2023. The lawsuit, Taylor et al. v. Nissan ...

Nissan is recalling 642,698 Rogue SUVs in the United States under two separate campaigns addressing defects that could lead to a loss of drive power, according to the National Highway Traffic Safety ...

Nissan Motor Co.’s shares climbed after the automaker narrowed its operating-loss forecast, touting progress in its cost-cutting drive to recover from its worst financial crisis in decades. The ...

Nissan Motor Co. said it’s progressing in a push to recover from its worst financial crisis in decades, with the automaker narrowing a full-year loss forecast as a cost-cutting drive ramps up. The ...

Nissan 7201-1.28%decrease; down pointing triangle Motor projected an annual net loss of $4.2 billion as it extended its streak of losses, hampered by U.S. tariffs and weaker sales while it forges ...

Nissan is charging $5,500 more for what’s essentially a rebadged Mitsubishi Outlander PHEV. Here’s what you get for the premium. The 2026 Nissan Rogue Plug-in Hybrid debuts in the U.S. as a rebadged ...

Bone metastasis is a devastating complication of non-small cell lung cancer (NSCLC), critically impairing patient survival. Nevertheless, the underlying molecular mechanisms driving this aggressive ...